Integra LifeSciences Holdings Price to Sales Ratio 2010-2024 | IART
Historical PS ratio values for Integra LifeSciences Holdings (IART) over the last 10 years. The current P/S ratio for Integra LifeSciences Holdings as of December 11, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Integra LifeSciences Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-12-11 | 24.15 | 1.20 | |
| 2024-09-30 | 18.17 | $20.07 | 0.91 |
| 2024-06-30 | 29.14 | $19.88 | 1.47 |
| 2024-03-31 | 35.45 | $19.18 | 1.85 |
| 2023-12-31 | 43.55 | $19.06 | 2.29 |
| 2023-09-30 | 38.19 | $18.88 | 2.02 |
| 2023-06-30 | 41.13 | $18.71 | 2.20 |
| 2023-03-31 | 57.41 | $18.77 | 3.06 |
| 2022-12-31 | 56.07 | $18.61 | 3.01 |
| 2022-09-30 | 42.36 | $18.59 | 2.28 |
| 2022-06-30 | 54.03 | $18.50 | 2.92 |
| 2022-03-31 | 64.26 | $18.31 | 3.51 |
| 2021-12-31 | 66.99 | $18.06 | 3.71 |
| 2021-09-30 | 68.48 | $17.88 | 3.83 |
| 2021-06-30 | 68.24 | $17.72 | 3.85 |
| 2021-03-31 | 69.09 | $16.21 | 4.26 |
| 2020-12-31 | 64.92 | $16.11 | 4.03 |
| 2020-09-30 | 47.22 | $16.12 | 2.93 |
| 2020-06-30 | 46.99 | $16.17 | 2.91 |
| 2020-03-31 | 44.67 | $17.57 | 2.54 |
| 2019-12-31 | 58.28 | $17.61 | 3.31 |
| 2019-09-30 | 60.07 | $17.61 | 3.41 |
| 2019-06-30 | 55.85 | $17.42 | 3.21 |
| 2019-03-31 | 55.72 | $17.36 | 3.21 |
| 2018-12-31 | 45.10 | $17.66 | 2.55 |
| 2018-09-30 | 65.87 | $17.76 | 3.71 |
| 2018-06-30 | 64.41 | $17.03 | 3.78 |
| 2018-03-31 | 55.34 | $16.21 | 3.41 |
| 2017-12-31 | 47.86 | $15.04 | 3.18 |
| 2017-09-30 | 50.48 | $13.61 | 3.71 |
| 2017-06-30 | 54.51 | $13.19 | 4.13 |
| 2017-03-31 | 42.13 | $12.78 | 3.30 |
| 2016-12-31 | 42.90 | $12.58 | 3.41 |
| 2016-09-30 | 41.28 | $12.73 | 3.24 |
| 2016-06-30 | 39.89 | $12.85 | 3.10 |
| 2016-03-31 | 33.68 | $12.82 | 2.63 |
| 2015-12-31 | 33.89 | $12.76 | 2.66 |
| 2015-09-30 | 29.78 | $11.70 | 2.55 |
| 2015-06-30 | 30.59 | $11.49 | 2.66 |
| 2015-03-31 | 28.00 | $11.88 | 2.36 |
| 2014-12-31 | 24.63 | $12.13 | 2.03 |
| 2014-09-30 | 22.54 | $11.22 | 2.01 |
| 2014-06-30 | 21.37 | $12.04 | 1.77 |
| 2014-03-31 | 20.88 | $12.17 | 1.72 |
| 2013-12-31 | 21.67 | $12.43 | 1.74 |
| 2013-09-30 | 18.28 | $14.77 | 1.24 |
| 2013-06-30 | 16.63 | $14.60 | 1.14 |
| 2013-03-31 | 17.71 | $14.62 | 1.21 |
| 2012-12-31 | 17.70 | $14.53 | 1.22 |
| 2012-09-30 | 18.66 | $14.22 | 1.31 |
| 2012-06-30 | 16.88 | $14.05 | 1.20 |
| 2012-03-31 | 15.75 | $13.58 | 1.16 |
| 2011-12-31 | 14.00 | $13.13 | 1.07 |
| 2011-09-30 | 16.24 | $12.90 | 1.26 |
| 2011-06-30 | 21.71 | $12.52 | 1.73 |
| 2011-03-31 | 21.53 | $12.26 | 1.76 |
| 2010-12-31 | 21.48 | $12.14 | 1.77 |
| 2010-09-30 | 17.92 | $12.05 | 1.49 |
| 2010-06-30 | 16.80 | $11.88 | 1.41 |
| 2010-03-31 | 19.90 | $11.78 | 1.69 |
| 2009-12-31 | 16.74 | $11.65 | 1.44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.864B | $1.542B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $204.393B | 24.93 |
| Intuitive Surgical (ISRG) | United States | $193.619B | 101.23 |
| Edwards Lifesciences (EW) | United States | $43.533B | 27.64 |
| Alcon (ALC) | Switzerland | $42.700B | 28.57 |
| IQVIA Holdings (IQV) | United States | $36.494B | 20.11 |
| IDEXX Laboratories (IDXX) | United States | $35.790B | 42.15 |
| DexCom (DXCM) | United States | $31.431B | 47.33 |
| Waters (WAT) | United States | $22.876B | 33.83 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.760B | 0.00 |
| Hologic (HOLX) | United States | $17.141B | 18.51 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.008B | 14.38 |
| Sysmex ADR (SSMXY) | Japan | $12.776B | 40.07 |
| Globus Medical (GMED) | United States | $11.294B | 28.60 |
| Penumbra (PEN) | United States | $9.735B | 95.36 |
| Masimo (MASI) | United States | $9.336B | 45.18 |
| Teleflex (TFX) | United States | $8.528B | 13.60 |
| Glaukos (GKOS) | United States | $7.879B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.728B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.717B | 26.73 |
| Inari Medical (NARI) | United States | $3.408B | 0.00 |
| Veracyte (VCYT) | United States | $3.372B | 101.19 |
| LivaNova (LIVN) | United Kingdom | $2.796B | 16.14 |
| Nihon Kohden (NHNKY) | Japan | $2.337B | 17.75 |
| Tandem Diabetes Care (TNDM) | United States | $2.267B | 0.00 |
| TransMedics (TMDX) | United States | $2.261B | 71.66 |
| Elekta AB (EKTAY) | Sweden | $2.229B | 20.04 |
| RxSight (RXST) | United States | $1.515B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.374B | 0.00 |
| Artivion (AORT) | United States | $1.254B | 83.11 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.062B | 0.00 |
| Paragon 28 (FNA) | United States | $0.874B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.859B | 14.60 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.708B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.699B | 16.49 |
| IRadimed (IRMD) | United States | $0.699B | 37.80 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.622B | 0.00 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.558B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 31.48 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.453B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.440B | 23.83 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.331B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.230B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.198B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.177B | 0.00 |
| Nevro (NVRO) | United States | $0.162B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.141B | 15.12 |
| Spectral Diagnostics (EDTXF) | Canada | $0.104B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.011B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |